CaltechAUTHORS
  A Caltech Library Service

Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial

Nord, Camilla L. and Halahakoon, D. Chamith and Limbachya, Tarun and Charpentier, Caroline and Lally, Níall and Walsh, Vincent and Leibowitz, Judy and Pilling, Stephen and Roiser, Jonathan P. (2019) Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial. Neuropsychopharmacology, 44 (9). pp. 1613-1622. ISSN 0893-133X. https://resolver.caltech.edu/CaltechAUTHORS:20190506-081614405

[img] MS Word - Supplemental Material
See Usage Policy.

631Kb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20190506-081614405

Abstract

Standard depression treatments, including antidepressant medication and cognitive behavioural therapy (CBT), are ineffective for many patients. Prefrontal transcranial direct current stimulation (tDCS) has been proposed as an alternative treatment, but has shown inconsistent efficacy for depression, and its mechanisms are poorly understood. We recruited unmedicated patients with major depressive disorder (N = 71 approached; N = 39 randomised) for a mechanistic, double-blind, randomized controlled trial consisting of eight weekly sessions of prefrontal tDCS administered to the left prefrontal cortex prior to CBT. We probed (1) whether tDCS improved the efficacy of CBT relative to sham stimulation; and (2) whether neural measures predicted clinical response. We found a modest and non-significant effect of tDCS on clinical outcome over and above CBT (active: 50%; sham: 31.6%; odds ratio: 2.16, 95% CI = 0.59–7.99), but a strong relationship, predicted a priori, between baseline activation during a working memory task in the stimulated prefrontal region and symptom improvement. Repeating our analyses of symptom outcome splitting the sample according to this biomarker revealed that tDCS was significantly superior to sham in individuals with high left prefrontal cortex activation at baseline; we also show 86% accuracy in predicting clinical response using this measure. Exploratory analyses revealed several other regions where activation at baseline was associated with subsequent response to CBT, irrespective of tDCS. This mechanistic trial revealed variable, but predictable, clinical effects of prefrontal tDCS combined with CBT for depression. We have discovered a potential explanation for this variability: individual differences in baseline activation of the region stimulated. Such a biomarker could potentially be used to pre-select patients for trials and, eventually, in the clinic.


Item Type:Article
Related URLs:
URLURL TypeDescription
https://doi.org/10.1038/s41386-019-0401-0DOIArticle
https://clinicaltrials.gov/ct2/show/NCT01875419?term=NCT01875419&rank=1Related ItemTrial Registration
ORCID:
AuthorORCID
Nord, Camilla L.0000-0002-9281-3417
Charpentier, Caroline0000-0002-7283-0738
Roiser, Jonathan P.0000-0001-8269-1228
Additional Information:© 2019 Springer Nature Publishing AG. Received 16 January 2019; Revised 21 March 2019; Accepted 15 April 2019; Published 30 April 2019. Data availability: All data discussed in the paper will be made available to any reader who enters into a managed access arrangement. Ethical and data governance restrictions prevent the data from being shared in a public repository (all data are patient data collected under UK National Health Service ethics and patients did not give consent for open sharing). All data will be shared freely following a formal Data Sharing Agreement with University College London. Researchers who wish to access the data should contact the senior author (j.roiser@ucl.ac.uk). Trial Registration: The trial was registered at clinicatrials.gov, registration number NCT01875419; URL: https://clinicaltrials.gov/ct2/show/NCT01875419?term=NCT01875419&rank=1. The authors would like to thank research assistants Jessica Alylward and Alan Gray for their help with data collection. They are also extremely grateful to the NHS clinicians Michaela Thomas, Dr Chinea Eziefula, Carlo Gittens, Laura Franklin, Dr Karen Katz, Dr Robin Weedon, Dr Jeremy Handel, Dr Flavia Cigolla, Akbar Jamil, Dr Isabella Foustanos, Dr Abi Harris, Dr Sukhvinder Virdee, Dr Jessica Wilner-Reid, and Dr Joshua Buckman, as well as all the patients who generously volunteered their time for the trial. Author Contributions: CLN, JPR, NL, SP, VV, and CC designed the study, CLN, CH, TL, and JL collected data, CLN analysed data, CLN and JPR wrote the paper with contributions from all the other authors. The authors declare no competing interests.
Funders:
Funding AgencyGrant Number
Brain Research TrustUNSPECIFIED
Brain and Behavior Research Foundation20162
University College LondonUNSPECIFIED
Subject Keywords:Cognitive control; Depression; Human behaviour
Issue or Number:9
Record Number:CaltechAUTHORS:20190506-081614405
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20190506-081614405
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:95228
Collection:CaltechAUTHORS
Deposited By: Tony Diaz
Deposited On:06 May 2019 16:15
Last Modified:28 May 2020 19:51

Repository Staff Only: item control page